GlassScriptPhysician profile
Ahmed A Shatla
NPI 1558351601
$5,554.50
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,602 · 2020: $1,568 · 2021: $288 · 2022: $96.51.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,149.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $605.56 | 2019-2021 | |
| Biogen, INC. | $571.16 | 2019-2022 | |
| Allergan, INC. | $409.98 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $224.75 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $215.73 | 2019 | |
| Arbor Pharmaceuticals, INC. | $198.56 | 2019-2020 | |
| Biotronik INC. | $195.96 | 2019 | |
| Amgen INC. | $173.92 | 2019-2020 | |
| Abbvie INC. | $159.41 | 2021 | |
| Avanir Pharmaceuticals, INC. | $152.81 | 2019 | |
| Emd Serono, INC. | $143.67 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $140.83 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $117.37 | 2020 | |
| Genentech USA, INC. | $108.11 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $98.77 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $95.64 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $89.58 | 2020 | |
| Sunovion Pharmaceuticals INC. | $76.89 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $69.28 | 2019 | |
| Neurocrine Biosciences, INC. | $67.16 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $59.90 | 2019-2020 | |
| Csl Behring | $56.43 | 2019-2020 | |
| Sk Life Science, INC. | $55.45 | 2020 | |
| Promius Pharma LLC | $49.18 | 2019 | |
| Ucb, INC. | $42.44 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $38.64 | 2021 | |
| Mdd US Operations, LLC | $33.18 | 2020 | |
| Lilly USA, LLC | $32.28 | 2019 | |
| Horizon Therapeutics Plc | $27.30 | 2019 | |
| Endo Pharmaceuticals INC. | $20.31 | 2019 | |
| Merck Sharp & Dohme LLC | $20.30 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.34 | 2019 | |
| Philips North America LLC | $13.15 | 2019 | |
| Tanabe Pharma America, INC. | $13.13 | 2020 | |
| Pfizer INC. | $12.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Shatla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.